Showing results (91-100 of 523) with videos related to

Sort By:
Pageof 53
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|February 1, 1992
In vivo quantification of cholesterol content in human carotid arteries by quantitative gamma-camera imaging after injection of autologous low density lipoproteins (LDL)I Virgolini, J O'Grady, G Lupattelli, et al.
Wiener Klinische Wochenschrift|September 23, 1988
[Return to work following myocardial infarct]F Rauscha, C Müller, H Kiss, et al.
Blood Pressure. Supplement|January 1, 1994
Isradipine increases platelet--low-density lipoprotein binding: evidence from ex-vivo studies in humansP Schmid, C Pirich, P Fitscha, et al.
European Journal of Clinical Pharmacology|January 1, 1997
Prostaglandin E1 decreases human arterial accumulation of radiolabeled apo B-containing lipoproteins in vivoH Kritz, H Sinzinger, G Lupattelli, et al.
Prostaglandins|July 1, 1991
Intravenous prostacyclin (PGI2) infusion to 108 patients with ischaemic peripheral vascular disease: phase II-open studyI Virgolini, P Fitscha, K Weiss, et al.
European Journal of Nuclear Medicine|January 1, 1991
Autologous low-density lipoprotein labelling allows characterization of human atherosclerotic lesions in vivo as to presence of foam cells and endothelial coverageI Virgolini, F Rauscha, G Lupattelli, et al.
Journal of Cardiovascular Pharmacology|March 1, 1993
Increase in in vivo low-density lipoprotein (LDL) receptor binding after PGE1 and 13,14-dihydro-PGE1 treatment in rabbitsH Sinzinger, I Virgolini, S R Li, et al.
Journal of Cardiovascular Pharmacology|April 1, 1991
Isradipine, a calcium-entry blocker, decreases vascular [125-I]low-density lipoprotein entry in hypercholesterolemic rabbitsH Sinzinger, G Lupattelli, I Virgolini, et al.
Prostaglandins, Leukotrienes, and Medicine|May 1, 1986
Prostacyclin synthesis stimulating plasma factor in patients with primary hyperlipoproteinemia--effect of dietary and drug treatmentH Sinzinger, J Kaliman, E Strobl-Jäger, et al.
Wiener Klinische Wochenschrift|July 15, 1988
[Fibrinolytic activity, thrombocyte function and pharmacokinetics during intra-arterial or intravenous prostaglandin E1 infusion in patients with chronic arterial occlusive disease]P Fitscha, T Simmet, B A Peskar, et al.
Pageof 53